These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36842726)

  • 1. Rapidly progressive interstitial lung disease in clinically amyopathic dermatomyositis triggered by a 23-valent pneumococcal polysaccharide vaccine.
    Suzuki K; Akiyama M; Kondo Y; Saito S; Kikuchi J; Hanaoka H; Kaneko Y
    Autoimmun Rev; 2023 May; 22(5):103307. PubMed ID: 36842726
    [No Abstract]   [Full Text] [Related]  

  • 2. Mycophenolate mofetil therapy for rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis.
    Tsuchiya H; Tsuno H; Inoue M; Takahashi Y; Yamashita H; Kaneko H; Kano T; Mimori A
    Mod Rheumatol; 2014 Jul; 24(4):694-6. PubMed ID: 24506658
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of MDA-5 antibody positive clinically amyopathic dermatomyositis associated interstitial lung disease: A systematic review.
    McPherson M; Economidou S; Liampas A; Zis P; Parperis K
    Semin Arthritis Rheum; 2022 Apr; 53():151959. PubMed ID: 35134633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful multi-target therapy using corticosteroid, tacrolimus, cyclophosphamide, and rituximab for rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis.
    Watanabe R; Ishii T; Araki K; Ishizuka M; Kamogawa Y; Fujita Y; Shirota Y; Fujii H; Harigae H
    Mod Rheumatol; 2016; 26(3):465-6. PubMed ID: 25698368
    [No Abstract]   [Full Text] [Related]  

  • 5. A case of anti-MDA5-positive rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis ameliorated by rituximab, in addition to standard immunosuppressive treatment.
    Koichi Y; Aya Y; Megumi U; Shunichi K; Masafumi S; Hiroaki M; Masahiko K; Shinsuke K; Manabu U; Kenichiro H; Fumiaki A; Nozomi A; Toshitaka M; Masayoshi Y; Chikako K; Yoshinao M; Tatsuo S; Masahiko K
    Mod Rheumatol; 2017 May; 27(3):536-540. PubMed ID: 25698373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of clinically amyopathic dermatomyositis despite aggressive immunosuppression with cyclophosphamide and prednisone.
    Hildebrand BA; Arroyo R
    J Clin Rheumatol; 2010 Apr; 16(3):143-5. PubMed ID: 20216327
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-MDA5 antibody-associated clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease.
    Horino T; Inotani S; Nakajima K; Ohnishi H; Komori M; Terada Y
    Joint Bone Spine; 2022 Nov; 89(6):105456. PubMed ID: 36108903
    [No Abstract]   [Full Text] [Related]  

  • 8. Correlation between disease activity and serum ferritin in clinically amyopathic dermatomyositis with rapidly-progressive interstitial lung disease: a case report.
    Yamada K; Asai K; Okamoto A; Watanabe T; Kanazawa H; Ohata M; Ohsawa M; Hirata K
    BMC Res Notes; 2018 Jan; 11(1):34. PubMed ID: 29338781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of hypomyopathic dermatomyositis associated with rapid progressive interstitial pneumonia resistant to multi-immunosuppressive therapy.
    Tsuda T; Asanuma Y; Koyama S; Kawabata Y; Moriguchi M
    Am J Med Sci; 2007 Mar; 333(3):185-90. PubMed ID: 17496740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapidly progressive interstitial lung fibrosis in a patient with amyopathic dermatomyositis and anti‑MDA5 antibodies.
    Górka J; Szczeklik W; Włudarczyk A; Łoboda P; Chmura Ł; Musiał J
    Pol Arch Med Wewn; 2015; 125(9):685-6. PubMed ID: 26200801
    [No Abstract]   [Full Text] [Related]  

  • 11. Nonspecific interstitial pneumonia with poor prognosis associated with amyopathic dermatomyositis.
    Sakamoto N; Mukae H; Fujii T; Yoshioka S; Kakugawa T; Yamaguchi H; Hayashi T; Kohno S
    Intern Med; 2004 Sep; 43(9):838-42. PubMed ID: 15497521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Living-donor lobar lung transplantation for rapidly progressive interstitial pneumonia associated with clinically amyopathic dermatomyositis: report of a case.
    Shoji T; Bando T; Fujinaga T; Chen F; Sasano H; Yukawa N; Mimori T; Date H
    Gen Thorac Cardiovasc Surg; 2013 Jan; 61(1):32-4. PubMed ID: 22618987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 34-year-old man with amyopathic dermatomyositis and rapidly progressive dyspnea with facial swelling. Diagnosis: pneumomediastinum and subcutaneous emphysema secondary to amyopathic dermatomyositis-associated interstitial lung disease.
    Powell C; Kendall B; Wernick R; Heffner JE
    Chest; 2007 Nov; 132(5):1710-3. PubMed ID: 17998377
    [No Abstract]   [Full Text] [Related]  

  • 14. An Autopsy Case of Anti-melanoma Differentiation-associated Gene-5 Antibody-positive Clinical Amyopathic Dermatomyositis Complicated by Rapidly Progressive Interstitial Lung Disease.
    Yoshida N; Kaieda S; Tomozoe K; Tajiri M; Wakasugi D; Okamoto M; Tominaga M; Ida H; Hoshino T
    Intern Med; 2016; 55(12):1653-9. PubMed ID: 27301523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically Amyopathic Dermatomyositis with Interstitial Pneumonia That Was Successfully Treated with Plasma Exchange.
    Yagishita M; Kondo Y; Terasaki T; Terasaki M; Shimizu M; Honda F; Oyama A; Takahashi H; Yokosawa M; Asashima H; Hagiwara S; Tsuboi H; Matsumoto I; Sumida T
    Intern Med; 2018 Jul; 57(13):1935-1938. PubMed ID: 29491297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Serum Ferritin Level Is Associated with the Treatment Responsivity for Rapidly Progressive Interstitial Lung Disease with Amyopathic Dermatomyositis, Irrespective of the Anti-MDA5 Antibody Level.
    Osawa T; Morimoto K; Sasaki Y; Matsuda S; Yamana K; Yano R; Uchiyama T; Goto H
    Intern Med; 2018 Feb; 57(3):387-391. PubMed ID: 29093381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Japanese-American female with rapidly progressive interstitial lung disease associated with clinically amyopathic dermatomyositis.
    Takada T; Asakawa K; Barrios R
    Clin Rheumatol; 2021 Mar; 40(3):1159-1165. PubMed ID: 32676922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyopathic dermatomyositis developing rapidly progressive interstitial lung disease with elevation of anti-CADM-140/MDA5 autoantibodies.
    Sato S; Kuwana M; Fujita T; Suzuki Y
    Mod Rheumatol; 2012 Aug; 22(4):625-9. PubMed ID: 22124544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors of rapidly progressive-interstitial lung disease in patients with clinically amyopathic dermatomyositis.
    Xu Y; Yang CS; Li YJ; Liu XD; Wang JN; Zhao Q; Xiao WG; Yang PT
    Clin Rheumatol; 2016 Jan; 35(1):113-6. PubMed ID: 26660480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapidly progressive interstitial lung disease in a patient with anti-MDA5-positive amyopathic dermatomyositis.
    Nandy A; Gaïni S; Sore P
    Scand J Rheumatol; 2018 Jul; 47(4):334-335. PubMed ID: 29043891
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.